Who writes this site
PeptideTalk PH is written by someone in Manila running the protocols. A Filipino-American living in the Philippines, with years of personal experience with peptides, regular bloodwork and a habit of reading the papers rather than the marketing.
I am not a doctor, a clinician or a researcher. What I bring is the view from here: what these compounds are, what the studies actually found, and what running them looks like in a country where the afternoon heat is brutal, the power goes out, and much of the advice online assumes you live in California.
Why this site exists
Most peptide information online is written for Americans. It assumes easy access to a telehealth clinic, a reliable cold chain from warehouse to door, and prices in dollars. None of that matches the Philippines.
Here, the questions are different:
- Is this registered with FDA Philippines, or is it a research compound?
- What does the pen actually cost at Watsons or Southstar, in pesos, this month?
- How do I keep a vial cold through a brownout, or a courier ride across Metro Manila in May?
- Where do I get IGF-1 or HbA1c tested, and what should I ask for?
The clinic route in Makati and BGC exists, but many people here piece the information together themselves from forums, Facebook groups and sellers' chat replies. This site is an attempt to put that information in one place, written from primary sources, with the Philippine context built in.
What this site is
A reference wiki. Each compound page covers what the molecule is, how it works, what human and animal studies found, side effects reported in those studies, and its status in the Philippines. Guides cover the questions that cut across compounds: sourcing, cost, side effects, bloodwork. Tools handle the arithmetic, such as reconstitution and syringe units.
It is not medical advice, and it is not a prescription. For approved medicines such as semaglutide and tirzepatide, prescribing belongs with a licensed Philippine physician.
Some compound and guide pages include a box linking to Primara Labs, a supplier with local stock in Metro Manila. The box sits beside the article, not inside it. The research sections are written from the cited sources, and nothing on this site is a claim about the quality of any supplier's product.
Editorial standards
Primary sources. Study findings come from the paper itself, the prescribing label or the trial registry: PubMed, NEJM, The Lancet, US FDA labels, ClinicalTrials.gov and FDA Philippines. Every compound page lists its references with links you can open.
Say what the evidence is. "In rats", "in a 12-person pilot" and "no human trials" appear whenever that is the truth. A mouse study is not presented as a human result.
No dosing recommendations. Doses appear only as doses used in published research, with the study, population and link. This site does not give anyone a dose to use.
No invented numbers. Every price, percentage and trial figure traces to a cited source. Pharmacy prices carry the date they were checked, because they change.
Dates on everything. Each page shows when it was last reviewed. Regulatory status, prices and trial results move, and a date lets you judge how fresh a page is.
Corrections. If something is wrong, out of date or missing a better source, say so. Post in the community or send a message there, and include the page and, ideally, the source. Confirmed errors get fixed and the review date updated.
Community
The discussion side lives on Reddit at r/phpeptideguide, where Filipino peptide users share logs, bloodwork, questions and sourcing principles. It is also the fastest way to reach me with a correction.
Disclaimer
Everything on PeptideTalk PH is educational. Research compounds are sold for research use only and are not registered as medicines in the Philippines. Talk to a licensed physician before starting, stopping or changing any medicine.